Tyrosol attenuates NASH features by reprogramming the hepatic immune milieu

In conclusion, Tyr effectively reduced NASH-related steatosis, fibrosis, oxidative stress, and inflammation, displaying a beneficial effect on the hepatic immune infiltrate, indicating its possible development as a therapeutic agent for NASH due to its multifaceted mechanism.PMID:38408597 | DOI:10.1016/j.ejphar.2024.176453

Source: European Journal of Pharmacology - February 26, 2024 Category: Drugs & Pharmacology Authors: Daniela Gabbia Katia Sayaf Ilaria Zanotto Martina Colognesi Yahima Frion-Herrera Maria Carrara Francesco Paolo Russo Sara De Martin Source Type: research